Am J Epidemiol 2003; 158:1193-1201.
Copyright © 2003 by the Johns
Hopkins Bloomberg School of Public Health
ORIGINAL CONTRIBUTIONS |
Case-Control Study of Bladder Cancer and Drinking Water Arsenic in the Western United States
1 Division of Occupational and Environmental Medicine, University of California, San Francisco, CA.
2 School of Public Health, University of California, Berkeley, CA.
Numerous epidemiologic investigations have identified links between high concentrations of arsenic in drinking water and cancer, although the risks at lower exposures are largely unknown. This paper presents the results of a case-control study of arsenic ingestion and bladder cancer in seven counties in the western United States. These counties contain the largest populations historically exposed to drinking water arsenic at concentrations near 100 µg/liter. All incident cases diagnosed from 1994 to 2000 were recruited. Individual data on water sources, water consumption patterns, smoking, and other factors were collected for 181 cases and 328 controls. Overall, no increased risks were identified for arsenic intakes greater than 80 µg/day (odds ratio = 0.94, 95% confidence interval: 0.56, 1.57; linear trend, p = 0.48). These risks are below predictions based on high dose studies from Taiwan. When the analysis was focused on exposures 40 or more years ago, an odds ratio of 3.67 (95% confidence interval: 1.43, 9.42; linear trend, p < 0.01) was identified for intakes greater than 80 µg/day (median intake, 177 µg/day) in smokers. These data provide some evidence that smokers who ingest arsenic at concentrations near 200 µg/day may be at increased risk of bladder cancer.
arsenic; bladder neoplasms; smoking; water supply
Abbreviations: Abbreviations: CI, confidence interval; HCFA, Health Care Financing Administration.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  G. Marshall, C. Ferreccio, Y. Yuan, M. N. Bates, C. Steinmaus, S. Selvin, J. Liaw, and A. H. Smith Fifty-Year Study of Lung and Bladder Cancer Mortality in Chile Related to Arsenic in Drinking Water J Natl Cancer Inst, June 20, 2007; 99(12): 920 - 928. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Hopenhayn Arsenic in Drinking Water: Impact on Human Health Elements, April 1, 2006; 2(2): 103 - 107. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D Ayotte, D. Baris, K. P Cantor, J. Colt, G. R Robinson Jr, J. H Lubin, M. Karagas, R. N Hoover, J. F Fraumeni Jr, and D. T Silverman Bladder cancer mortality and private well use in New England: an ecological study J. Epidemiol. Community Health, February 1, 2006; 60(2): 168 - 172. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Steinmaus, Y. Yuan, D. Kalman, R. Atallah, and A. H. Smith Intraindividual Variability in Arsenic Methylation in a U.S. Population Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 919 - 924. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Michaud, M. E. Wright, K. P. Cantor, P. R. Taylor, J. Virtamo, and D. Albanes Arsenic Concentrations in Prediagnostic Toenails and the Risk of Bladder Cancer in a Cohort Study of Male Smokers Am. J. Epidemiol., November 1, 2004; 160(9): 853 - 859. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. N. Bates, O. A. Rey, M. L. Biggs, C. Hopenhayn, L. E. Moore, D. Kalman, C. Steinmaus, and A. H. Smith Case-Control Study of Bladder Cancer and Exposure to Arsenic in Argentina Am. J. Epidemiol., February 15, 2004; 159(4): 381 - 389. [Abstract] [Full Text] [PDF]
|
|